In cancers, aberrations of the FGFR4 genomic region include the amplification of FGFR4, activation of FGFR4 kinase domain mutations, and overexpression of FGFR4, which lead to sustained cell proliferation and contribute to tumor development [3]. Here, FGFR4 is linked to cancer.